Published November 11, 2021 | Version v1
Patent Open

COMPOSITION AND METHODS FOR TUMOR IMAGING AND TREATMENT

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Radioisotope-labeled small molecule activity-based probes that target the cancer associated serine hydrolase neutral cholesterol ester hydrolase 1 (NCEH1) are described. The probes can undergo a reaction with the NCEH1, resulting in covalent bonding of a portion of the probe molecule to the NCEH1. Also described are methods of labeling NCEH1 in biological samples, such as cells or tissue, and methods of visualizing tumors using the radioisotope-labeled NCEH1 probes as tracer compounds, either alone or in combination with assessing the efficacy of a cancer treatment or potential cancer treatment.

Files

US20210346525.pdf

Files (4.9 MB)

Name Size Download all
md5:84b3f875347adc7517b74ce616ad854f
4.9 MB Preview Download

Additional details

Identifiers

Patent application number
US 202117317529 A
Patent number
US 2021/0346525 A1
Other
oai:uchicago.tind.io:9178

Dates

Patent filed
2021-05-11

UChicago Information

Division(s)
Physical Sciences Division
Department(s)
Chemistry